Breast lesions and cancer: histopathology and molecular classification in a referral hospital in Ghana

References

• Javed A, Lteif A. Development of the human breast. Semin Plast Surg. 2013;27(1):5–12.
   Web of Science ®Google Scholar
• Russo J, Lynch H, Russo IH. Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J. 2001;7(5):278–291.
   Google Scholar
• Neville MC, Neifert MR, eds. Lactation; physiology, nutrition, and breast-feeding. Boston, MA: Springer US; 1983. DOI:https://doi.org/10.1007/978-1-4613-3688-4
   Google Scholar
• Chinyama CN. Overview of benign breast lesions. In: Benign breast diseases. 2nd ed. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014. p. 9–16. DOI:https://doi.org/10.1007/978-3-642-41065-9_2
   Google Scholar
• De Silva NK. Breast development and disorders in the adolescent female. Best Pract Res Clin Obstet Gynaecol. 2018;48(September):40–50.
   Google Scholar
• Onstad M, Stuckey A. Benign breast disorders. Obstet Gynecol Clin North Am. 2013;40(3):459–473.
   Web of Science ®Google Scholar
• Dyrstad SW, Yan Y, Fowler AM, et al. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res Treat. 2015;149(3):569–575.
   PubMed Web of Science ®Google Scholar
• Sasaki J, Geletzke A, Kass RB, et al. Etiology and management of benign breast disease. In: The breast. 5th ed. Elsevier; 2018. p. 79–92.e5. DOI:https://doi.org/10.1016/B978-0-323-35955-9.00005-2
   Google Scholar
• Ibrahim I, Iliyasu Y, Mohammed A. Histopathological review of breast tumors in Kano, Northern Nigeria. Sub-Saharan African J Med. 2015;2(1):47.
   Google Scholar
• Alexander Femi A. Profile of benign breast diseases in an African population. J Surg. 2016;4(2):35.
   Google Scholar
• Ohene-Yeboah MOK. An audit of excised breast lumps in Ghanaian women. West Afr J Med. 2005;24(3):252–255.
   Google Scholar
• Ohene-Yeboah M, Amaning E. Spectrum of complaints presented at a specialist breast clinic in Kumasi, Ghana. Ghana Med J. 2009;42(3):110–112.
   Google Scholar
• Adjei E, Ohene-Yeboah M. Breast cancer in Kumasi, Ghana. Ghana Med J. 2012;46(1):13.
   Google Scholar
• Thomas AS, Osei-bonsu E. Breast cancer in Ghana: demonstrating the need for population-based cancer registries in low- and middle-income countries. J Glob Oncol. 2017;3(6):765–772.
   Web of Science ®Google Scholar
• Allison KH, Hammond MEH, Dowsett M, et al. Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update. J Clin Oncol. 2020;38(12):1346–1366.
   PubMed Web of Science ®Google Scholar
• Wolff AC, Elizabeth Hale Hammond M, Allison KH, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/ College of American Pathologists Clinical Practice guideline focused update. J Clin Oncol. 2018;36(20):2105–2122.
   PubMed Web of Science ®Google Scholar
• Abubakar M, Orr N, Daley F, et al. Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups. Breast Cancer Res. 2016;18(1):1–13.
   Google Scholar
• Torous VF, Schnitt SJ, Collins LC. Benign breast lesions that mimic malignancy. Pathology. 2017;49(2):181–196.
   Web of Science ®Google Scholar
• Brinton L, Figueroa J, Adjei E, et al. Factors contributing to delays in diagnosis of breast cancers in Ghana, West Africa. Breast Cancer Res Treat. 2017;162(1):105–114.
   Web of Science ®Google Scholar
• Edmund DM, Naaeder SB, Tettey Y, et al. Breast cancer in Ghanaian women. Am J Clin Pathol. 2013;140(1):97–102.
   Web of Science ®Google Scholar
• Vanderpuye V, Grover S, Hammad N, et al. An update on the management of breast cancer in Africa. Infect Agent Cancer. 2017;12(1):13.
   Google Scholar
• Gyan E, Derkyi-Kwarteng L, Brown AA, et al. Benign breast conditions: an eight-year single-centre histopathological review of women presenting with mass lesions at the Korle-Bu Teaching Hospital, Ghana. Ann Diagn Pathol. 2019;42:33–38.
   Web of Science ®Google Scholar
• Forae G, Igbe A, Ijomone E, et al. Benign breast diseases in Warri Southern Nigeria: a spectrum of histopathological analysis. Ann Niger Med. 2014;8(1):28.
   Google Scholar
• Ugiagbe E, Olu-Eddo A. Benign breast lesions in an African population: a 25-year histopathological review of 1864 cases. Niger Med J. 2011;52(4):211.
   Google Scholar
• Nwafor CC, Keshinro S. The pathology of breast biopsies in a sample of Nigerian patients: review and analysis. Ann AFRICAN Surg. 2015;12(2):89–94.
   Google Scholar
• Chalya PL, Manyama M, Rambau PF, et al. Clinicopathological pattern of benign breast diseases among female patients at a tertiary health institution in Tanzania. Tanzan J Health Res. 2016;18(1):1–9.
   Google Scholar
• Nwafor C, Udo I. Histological characteristics of breast lesions in Uyo, Nigeria. Niger J Surg. 2018;24(2):76.
   Google Scholar
• Siddiqui MS, Kayani N, Pervez S, et al. Breast diseases: a histopathological analysis of 3279 cases at a tertiary care center in Pakistan. J Pakistan. 2003;53(March):94–97.
   Google Scholar
• Ciatto S, Bonardi R, Ravaioli A, et al. Benign breast surgical biopsies: are they always justified? Tumori J. 1998;84(5):521–524.
   Web of Science ®Google Scholar
• Khan A, Jan H, Rafiq MS, et al. Types of breast lumps in a tertiary care hospital. J Med Sci. 2016;24(3):133–135.
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A J Clin. 2018;1–31. DOI:https://doi.org/10.3322/caac.21492
   Google Scholar
• Torre LA, Siegel RL, Ward EM, et al. Global cancer incidence and mortality rates and trends – an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16–27.
   PubMed Web of Science ®Google Scholar
• Joko-fru WY, Miranda-filho A, Soerjomataram I, et al. Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index: a population-based registry study. Int J Cancer. 2020;146(May2019):1208–1218.
   Google Scholar
• Mensah AC, Yarney J, Nokoe SK, et al. Survival outcomes of breast cancer in Ghana: an analysis of clinicopathological features. Open Access Libr J. 2016;3(e2145):1–11.
   Google Scholar
• Wiredu EK, Armah HB. Cancer mortality patterns in Ghana: a 10-year review of autopsies and hospital mortality. BMC Public Health. 2006;6(159):1–7.
   Google Scholar
• Sanuade OA, Ayettey H, Hewlett S, et al. Understanding the causes of breast cancer treatment delays at a teaching hospital in Ghana. Journal of Health Psychology 2018. DOI:https://doi.org/10.1177/1359105318814152
   Google Scholar
• Zelle SG, Nyarko KM, Bosu WK, et al. Costs, effects and cost-effectiveness of breast cancer control in Ghana. Trop Med Int Heal. 2012;17(8):1031–1043.
   Web of Science ®Google Scholar
• Aziato L, Clegg-Lamptey JNA. Breast cancer diagnosis and factors influencing treatment decisions in Ghana. Health Care Women Int. 2015;36(5):543–557.
   PubMed Web of Science ®Google Scholar
• Obrist M, Osei-Bonsu E, Ahwah B, et al. Factors related to incomplete treatment of breast cancer in Kumasi, Ghana. Breast. 2014;23(6):821–828.
   PubMed Web of Science ®Google Scholar
• Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, et al. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017;67(5):378–397.
   PubMed Web of Science ®Google Scholar
• Pace LE, Shulman LN. Breast cancer in sub‐Saharan Africa: challenges and opportunities to reduce mortality. Oncologist. 2016;21(6):739–744.
   Web of Science ®Google Scholar
• Ghana Statistical Service. Ghana population and housing census 2010; 2012.
   Google Scholar
• Ofori-Asenso R, Agyeman AA, Laar A, et al. Overweight and obesity epidemic in Ghana – a systematic review and meta-analysis. BMC Public Health. 2016;16(1):1239.
   PubMedGoogle Scholar
• Lartey ST, Magnussen CG, Si L, et al. Rapidly increasing prevalence of overweight and obesity in older Ghanaian adults from 2007-2015: evidence from WHO-SAGE Waves 1 & 2. Ahmad R, ed. PLoS One. 2019;14(8):e0215045.
   PubMed Web of Science ®Google Scholar
• Ahmed S, Choi Y, Rimon JG, et al. Trends in contraceptive prevalence rates in sub-Saharan Africa since the 2012 London summit on family planning: results from repeated cross-sectional surveys. Lancet Glob Heal. 2019;7(7):e904–e911.
   PubMed Web of Science ®Google Scholar
• Quayson SE, Wiredu EK, Adjei DN, et al. Breast cancer in Accra, Ghana. J Med Biomed Sci. 2014;3(3):21–26.
   Google Scholar
• Laryea DO, Awuah B, Amoako YA, et al. Cancer incidence in Ghana, 2012: evidence from a population-based cancer registry. BMC Cancer. 2014;14(1):362.
   Google Scholar
• Amoako YA, Awuah B, Larsen-Reindorf R, et al. Malignant tumours in urban Ghana: evidence from the city of Kumasi. BMC Cancer. 2019;19(1):267.
   PubMedGoogle Scholar
• Evans M, Shaaban AM. Breast cancer in sub-Saharan Africa. In: Adedeji OA, editor. Cancer in sub-Saharan Africa; current practice and future. Springer; 2016. p. 81–93. DOI:https://doi.org/10.1007/978-3-319-52554-9
   Google Scholar
• Seshie B, Adu-Aryee NA, Dedey F, et al. A retrospective analysis of breast cancer subtype based on ER/PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital, Ghana. BMC Clin Pathol. 2015;15(1):14.
   Google Scholar
• Makanjuola S, Ayodele S, Javid F, et al. Breast cancer receptor status assessment and clinicopathological association in Nigerian women: a retrospective analysis. J Cancer Res Ther. 2014;2(8):122–127.
   Google Scholar
• Newman LA. Disparities in breast cancer and African ancestry: a global perspective. Breast J. 2015;21(2):133–139.
   PubMed Web of Science ®Google Scholar
• Bianchini G, Balko JM, Mayer IA, et al. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13(11):674–690.
   PubMed Web of Science ®Google Scholar
• Denkert C, Liedtke C, Tutt A, et al. Molecular alterations in triple-negative breast cancer – the road to new treatment strategies. Lancet. 2017;389(10087):2430–2442.
   PubMed Web of Science ®Google Scholar
• Adjei EK, Owusu-Afriyie O, Awuah B, et al. Hormone receptors and Her2 expression in breast cancer in sub-Saharan Africa. A comparative study of biopsies from Ghana and Norway. Breast J. 2014;20(3):308–311.
   Web of Science ®Google Scholar
• Titiloye NA, Foster A, Omoniyi-Esan GO, et al. Histological features and tissue microarray taxonomy of Nigerian breast cancer reveal predominance of the high-grade triple-negative phenotype. Pathobiology. 2016;83(1):24–32.
   Web of Science ®Google Scholar
• Minoza KG, Yawe KT, Mustapha Z, et al. Hormonal and HER2 receptor immunohistochemistry of breast cancer in North-Eastern Nigeria: a preliminary report. IOSR J Dent Med Sci. 2016;15(6):18–23.
   Google Scholar
• Usman A, Iliyasu Y, Atanda AT. Molecular subtyping of carcinoma of the female breast in a tertiary teaching hospital in Northern Nigeria. Ann Trop Pathol. 2019;10(1):20–26.
   Google Scholar